Funding Details
- Awarder
- Inbox
- Date Award
- May 20, 2025
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
Company Info
- Traction
- Total amount raised by the company to date is EUR 116 million.
- Company Description
- Orbis Medicines is focused on pioneering a new era for oral macrocycle drug discovery, developing high-value oral alternatives to blockbuster biologic drugs.
- Market
- Oral macrocycle drugs
- Location
-
Epalinges,
Switzerland
- Coinvestors
- NEA, Eli Lilly and Company, Cormorant, Export and Investment Fund of Denmark, Novo Holdings, Forbion
Links